FHA
FBRX icon

Flagship Harbor Advisors’s Forte Biosciences FBRX Stock Holding History

Flagship Harbor Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed -$1K – 916
2020
Q3 		$1K Hold
1
– – ﹤0.01% 1811
2020
Q2 		$0 Hold
1
– – ﹤0.01% 2047
2020
Q1 		$1K Hold
1
– – ﹤0.01% 1732
2019
Q4 		$0 Hold
1
– – ﹤0.01% 1895
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1879
2019
Q2 		$3K Hold
1
– – ﹤0.01% 1605
2019
Q1 		$5K Hold
1
– – ﹤0.01% 1486
2018
Q4 		$4K Buy
+1
New +$4.31K ﹤0.01% 1491

Other funds holding FBRX

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Flagship Harbor Advisors's FBRX Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Forte Biosciences (FBRX) in Q4 2020, closing a stake of 1 share — an estimated $1K sold.

Flagship Harbor Advisors first reported a position in FBRX in Q4 2018 and held it in 8 quarters. The position peaked at $5K in Q1 2019. 49 funds tracked by Wall St. Rank hold FBRX as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Forte Biosciences position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1 Forte Biosciences share in Q4 2020, an estimated $1K.
  • Flagship Harbor Advisors first reported a position in Forte Biosciences in Q4 2018 and held it in 8 quarters.
  • Flagship Harbor Advisors's Forte Biosciences position peaked at $5K in Q1 2019.
  • 49 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.